Formulation Development Solutions

  1. Early Development: Accelerating Molecules Through To Proof-Of-Concept 3/3/2022

    Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.

  2. Keep A Close Eye On Quality With Excipients For Drug Formulation 8/27/2025

    Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.

  3. The Device Of Choice For Applications Requiring Higher Yield 10/16/2025

    High-flux membranes enable scalable filtration of biologics even under harsh conditions. Ideal for high-viscosity feeds, these cassettes support efficient processing and reliable cleanability.

  4. Laboratory Services 3/2/2026

    Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.

  5. Disposable Pen For The Self-Injection Of Chronic Disease Medications 11/8/2021

    This device is designed for use with a wide range of drug therapies that require variable dosing.

  6. A Quick Guide To Dissolution Testing 4/1/2022

    What is dissolution testing? Why is it critical? What should you consider for your method validation? Find answers to these questions and more in this quick guide to dissolution testing.

  7. Human Proximal Tubule Kidney Bio-Kit 4/9/2024

    Discover a co-culture human kidney model that enables researchers to evaluate drug candidate toxicity at clinically relevant dosing concentrations.

  8. Empowering Biologics Development With HRMS Services 7/3/2025

    Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.

  9. Oligonucleotide CDMO: From Preclinical To Commercial 3/11/2026

    See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.

  10. Drug Delivery Materials 3/11/2026

    Learn how tailored lipids, polymers, and carbohydrate‑based materials strengthen targeted delivery, enhance stability, and support scalable development for emerging therapeutic modalities.